Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Can Peking Criteria accurately interpreting interim and end-of-treatment 18F-FDG PET/CT for the prognosis of patients with diffuse large B cell lymphoma?

Yuewei Zhang, Yang Fan, Zhi Yang and Xuejuan Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1602;
Yuewei Zhang
2Department of nuclear medicine Peking University Cancer Hospital & Institute Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Fan
1Peking University Cancer Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang
1Peking University Cancer Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejuan Wang
1Peking University Cancer Hospital Beijing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1602

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Yuewei Zhang2,
  2. Yang Fan1,
  3. Zhi Yang1 and
  4. Xuejuan Wang1
  1. 1Peking University Cancer Hospital Beijing China
  2. 2Department of nuclear medicine Peking University Cancer Hospital & Institute Beijing China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016200
Jun 20162700
Jul 2016900
Aug 2016300
Sep 20161400
Oct 2016600
Nov 2016400
Dec 2016600
Jan 20171000
Feb 2017500
Mar 20171100
Apr 2017700
May 2017300
Jun 20171400
Jul 2017700
Aug 2017900
Sep 2017300
Oct 2017600
Nov 2017400
Dec 20172400
Jan 2018300
Feb 2018300
Mar 2018800
Apr 2018400
May 20181100
Jun 2018100
Aug 2018200
Sep 2018600
Oct 2018900
Dec 2018700
Jan 20191100
Feb 20191300
Mar 20191800
Apr 20191100
Jun 2019200
Jul 2019500
Aug 2019300
Sep 2019100
Nov 2019300
Jan 2020200
Feb 2020400
Mar 20201400
Apr 2020900
May 2020400
Jul 2020600
Aug 20201300
Sep 20202900
Oct 20201700
Nov 20201800
Dec 20201100
Jan 2021300
Feb 2021800
Mar 20212500
Apr 20214700
May 20211500
Jun 2021200
Jul 20211900
Aug 20214000
Sep 20211500
Oct 20211900
Nov 20218600
Dec 20214800
Jan 20228800
Feb 20222600
Mar 20221900
Apr 20221000
May 20222700
Jun 2022500
Aug 2022200
Oct 2022400
Dec 2022100
Jan 2023200
Feb 2023200
Mar 2023100
Apr 2023200
May 2023100
Jun 2023300
Jul 2023100
Aug 2023600
Sep 2023100
Oct 2023200
Nov 2023200
Dec 2023500
Jan 2024300
Feb 2024100
Mar 2024100
Apr 2024400
May 2024300
Jun 2024300
Jul 2024100
Aug 2024700
Sep 2024500
Oct 2024400
Nov 2024500
Dec 2024400
Jan 2025500
Feb 2025600
Mar 2025300
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can Peking Criteria accurately interpreting interim and end-of-treatment 18F-FDG PET/CT for the prognosis of patients with diffuse large B cell lymphoma?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Can Peking Criteria accurately interpreting interim and end-of-treatment 18F-FDG PET/CT for the prognosis of patients with diffuse large B cell lymphoma?
Yuewei Zhang, Yang Fan, Zhi Yang, Xuejuan Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1602;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can Peking Criteria accurately interpreting interim and end-of-treatment 18F-FDG PET/CT for the prognosis of patients with diffuse large B cell lymphoma?
Yuewei Zhang, Yang Fan, Zhi Yang, Xuejuan Wang
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1602;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Relationships between preoperative FMISO- and FDG-PET parameters and the prognosis in patients with oral squamous cell carcinoma
  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • STANDARDIZATION OF TUMOR VOLUME DELINEATION BY PET-CT AND CT IN PATIENTS OF HEAD AND NECK CANCER-A PRELIMINARY ANALYSIS
Show more Oncology, Clinical Science Track

MTA I: Leukemia/Lymphoma/Myeloma Posters

  • Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.
  • Lung invasive fungal infection (IFI) in acute myeloid leukemia (AML) patients: role of 18-FDG-PET/CT
  • Prospective Comparison of 11C-4DST, 18F-FDG PET/CT and whole-body MRI in the patients with multiple myeloma
Show more MTA I: Leukemia/Lymphoma/Myeloma Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire